X-77663515-T-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000489.6(ATRX):āc.3987A>Gā(p.Glu1329=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,209,383 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000489.6 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.3987A>G | p.Glu1329= | synonymous_variant | 12/35 | ENST00000373344.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATRX | ENST00000373344.11 | c.3987A>G | p.Glu1329= | synonymous_variant | 12/35 | 1 | NM_000489.6 | P3 | |
ATRX | ENST00000395603.7 | c.3873A>G | p.Glu1291= | synonymous_variant | 11/34 | 1 | A2 | ||
ATRX | ENST00000624166.3 | c.3783A>G | p.Glu1261= | synonymous_variant | 12/14 | 1 | |||
ATRX | ENST00000480283.5 | c.*3615A>G | 3_prime_UTR_variant, NMD_transcript_variant | 13/36 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000187 AC: 21AN: 112113Hom.: 0 Cov.: 23 AF XY: 0.000233 AC XY: 8AN XY: 34265
GnomAD3 exomes AF: 0.0000659 AC: 12AN: 182058Hom.: 0 AF XY: 0.0000450 AC XY: 3AN XY: 66650
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1097270Hom.: 0 Cov.: 30 AF XY: 0.0000221 AC XY: 8AN XY: 362668
GnomAD4 genome AF: 0.000187 AC: 21AN: 112113Hom.: 0 Cov.: 23 AF XY: 0.000233 AC XY: 8AN XY: 34265
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Alpha thalassemia-X-linked intellectual disability syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at